Viking Therapeutics
VKTX
#2410
Rank
S$8.25 B
Marketcap
$74.05
Share price
-9.14%
Change (1 day)
448.83%
Change (1 year)

Earnings for Viking Therapeutics (VKTX)

Earnings in 2024 (TTM): -S$0.14 Billion

According to Viking Therapeutics 's latest financial reports the company's current earnings are N/A. In 2023 the company made an earning of -S$0.12 Billion a decrease over its 2022 earnings that were of -S$92.63 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Viking Therapeutics from 2014 to 2024

Annual earnings

Year Earnings Change
2024 (TTM) -S$0.14 Billion13.85%
2023 -S$0.12 Billion24.73%
2022 -S$92.63 Million25.24%
2021 -S$73.96 Million39.23%
2020 -S$53.12 Million53.21%
2019 -S$34.68 Million16.84%
2018 -S$29.68 Million7.22%
2017 -S$27.68 Million39.68%
2016 -S$19.82 Million-37.05%
2015 -S$31.48 Million6.94%
2014 -S$29.44 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
-S$0.7 Billion 424.51%๐Ÿ‡บ๐Ÿ‡ธ USA
S$5.06 M-103.80%๐Ÿ‡บ๐Ÿ‡ธ USA
S$28.85 M-121.64%๐Ÿ‡บ๐Ÿ‡ธ USA